Dragon Pharma SS-31 50 mg - Elamipretide Lyophilized Vial

Dragon Pharma SS-31 50 mg Elamipretide Research Vial

Dragon Pharma SS-31 is a 50 mg lyophilized research vial of elamipretide, also written MTP-131 in earlier literature. The sequence D-Arg-Dmt-Lys-Phe-NH2 concentrates on the inner mitochondrial membrane and binds cardiolipin, the phospholipid that keeps the energy-transducing complexes in shape. In 2025 a U.S. accelerated approval went to an elamipretide medicine for Barth syndrome, a rare mitochondrial disorder, which is the narrow clinical frame around a research material.

• 50 mg lyophilized powder, single vial, research use
• Cardiolipin-binding mitochondrial tetrapeptide
• GMP-manufactured and HPLC-verified - COA on file per batch
• U.S. domestic and international shipping

How SS-31 Works

Elamipretide is studied as a cardiolipin binder: sitting on the inner membrane, it is thought to protect cristae structure and help the electron transport chain keep producing ATP under stress. The approved label reports a peak 0.5 to 1 hour after a subcutaneous dose, about 92 percent bioavailability and near-complete urinary recovery by 48 hours. The boundary is clinical: the pivotal phase 3 trial in primary mitochondrial myopathy failed its primary endpoints, and the Barth syndrome approval rests on a small program with a confirmatory study still required, so healthy-user claims outrun the evidence. The metabolic side of the shelf is covered on the MOTS-c and AICAR pages.

Reconstitution & Storage

The lyophilizate is dissolved with bacteriostatic water added down the vial wall, without shaking. A 50 mg vial in 5 ml gives 10 mg/ml, where 1 mg is 0.1 ml or 10 units on a U-100 syringe; 10 ml gives 5 mg/ml. Vendor protocols mention 1 to 5 mg daily in 4 to 12 week blocks, which is practice rather than evidence. For reference, the approved medicine is dosed at 40 mg once daily in Barth syndrome, a different product from this vial. Store the powder at 2-8 C, away from light, and use a reconstituted solution within about 28 to 30 days. Bacteriostatic water is the usual diluent for this line.

Quality & Authenticity

Each batch is GMP-made and checked by third-party HPLC, with a Certificate of Analysis held per batch. Injection site reactions are the most common complaint in the clinical program, so rotate sites and keep the technique clean. If you want the metabolic peptide rather than the cardiolipin binder, the NAD+ page shows how the neighbouring research items are grouped.

For laboratory research only. Consult a healthcare professional before use.

Research compounds only. Consult a healthcare professional before any use. Amounts shown are vendor protocol ranges, not clinical doses.